ST英飛拓(002528.SZ):2024年淨虧損4.04億元
格隆匯4月29日丨ST英飛拓(002528.SZ)發佈2024年年度報吿,2024年,公司持續深入推進資源整合與業務結構優化,聚焦核心主業發展質量。因為子公司新普互聯的互聯網營銷業務規模和毛利率持續下降,公司對其採取了收縮經營策略,公司的營業收入下降。同時通過整合資源賦能海外子公司提高核心競爭力,積極採取嚴控業務項目質量、加強內控風險管理、壓縮三費支出、控制融資規模、加大應收賬款催收力度等一系列降本減費、提質增效工作舉措,公司的淨利潤同比減虧。公司2024年度實現營業收入9.45億元,同比減少32.35%;歸屬於上市公司股東的淨利潤-4.04億元,同比減虧47.63%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.